Table 1 Baseline characteristics

Males/females

12/17

14/14

0.514

Age (years)

58.1 ± 12.1

63.9 ± 12.2

0.080

Duration of diabetes (years)

16.0 ± 8.3

18.5 ± 10.0

0.309

Body weight (kg)

82.0 ± 16.2

76.6 ± 15.5

0.122

Body mass index (kg/m²)

31.3 ± 5.3

29.1 ± 3.0

0.102

HbA1c (%)

8.5 ± 1.4

9.4 ± 1.6

0.023

Fasting plasma glucose (mg/dL)

159.0 ± 49.7

156.4 ± 59.2

0.655

Fasting C-peptide (mg/dL)

2.09 ± 0.97

1.97 ± 0.24

0.267

Low-density lipoprotein-cholesterol (mg/dL)

113.1 ± 36.5

116.6 ± 28.2

0.689

High-density lipoprotein-cholesterol (mg/dL)

44.2 ± 8.1

46.1 ± 13.8

0.534

Triglycerides (mg/dL)

149.4 ± 55.2

201.2 ± 145.0

0.432

Hypertension (%)

83

86

0.760

Dyslipidemia (%)

90

86

0.650

Previous treatment

Biguanide (%)

38

18

0.092

Sulfonylurea (%)

31

21

0.410

Alpha-glucosidase inhibitor (%)

17

29

0.308

Thiazolidinedione (%)

21

14

0.525

DPP-IV inhibitor (%)

10

7

0.669

Glinide (%)

3

0

0.322

Insulin (%)

55

82

0.029